Deerfield Management’s Vera Therapeutics VERA Stock Holding History

Deerfield Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$168M	Buy	3,916,400 +194,300	+5%	+$7.24M	1.75%	14
2026 Q1	$150M	Sell	3,722,100 -337,595	-8%	-$14.5M	1.77%	14
2025 Q4	$206M	Buy	4,059,695 +418,538	+11%	+$14.9M	2.63%	9
2025 Q3	$106M	Buy	3,641,157 +293,040	+9%	+$6.78M	1.62%	13
2025 Q2	$78.9M	Buy	3,348,117 +2,298,117	+219%	+$51.7M	1.43%	20
2025 Q1	$25.2M	Buy	+1,050,000	New	+$33.7M	0.5%	42
2024 Q3	–	Sell	-6,191	Closed	-$224K	–	656
2024 Q2	$224K	Sell	6,191 -4,017	-39%	-$159K	﹤0.01%	388
2024 Q1	$440K	Buy	+10,208	New	+$364K	0.01%	167
2023 Q2	–	Sell	-1,300,000	Closed	-$10.1M	–	111
2023 Q1	$10.1M	Buy	+1,300,000	New	+$10M	0.22%	73

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management's VERA Position: Q2 2026 in Review

Deerfield Management increased its Vera Therapeutics (VERA) stake by 5.2% in Q2 2026, buying an estimated $7.24M and bringing the position to 3,916,400 shares worth $168M. The position accounts for 1.75% of the portfolio, ranked #14.

Deerfield Management first reported a position in VERA in Q1 2023 and has held it in 9 quarters since. The position peaked at $206M in Q4 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Deerfield Management held 3,916,400 shares of Vera Therapeutics worth $168M as of Q2 2026.
Deerfield Management bought 194,300 Vera Therapeutics shares in Q2 2026, an estimated $7.24M.
Vera Therapeutics made up 1.75% of Deerfield Management's portfolio in Q2 2026, its #14 holding.
Deerfield Management first reported a position in Vera Therapeutics in Q1 2023 and has held it in 9 quarters since.
Deerfield Management's Vera Therapeutics position peaked at $206M in Q4 2025.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.